Tamoxifen Citrate (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Tamoxifen Citrate drug offered from KAISER FOUNDATION HOSPITALS. This Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: Tamoxifen Citrate
SUBSTANCE NAME: TAMOXIFEN CITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-01-12
END MARKETING DATE: 0000-00-00


Tamoxifen Citrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTamoxifen Citrate from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2017-01-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0224_c2ed44db-3334-4a0f-8725-ab7b2e95431d
PRODUCT NDC: 0179-0224
APPLICATION NUMBER: ANDA075797

Other TAMOXIFEN CITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
A-S Medication SolutionsTamoxifen Citrate
Actavis Pharma, Inc.Tamoxifen Citrate
American Health PackagingTamoxifen Citrate
Bryant Ranch PrepackTamoxifen Citrate
Golden State Medical Supply, Inc.Tamoxifen Citrate
KAISER FOUNDATION HOSPITALSTamoxifen Citrate
Mayne Pharma Inc.Tamoxifen Citrate
McKesson Packaging Services Business Unit of McKesson CorporationTamoxifen Citrate
Mylan Pharmaceuticals Inc.Tamoxifen Citrate
Physicians Total Care, Inc.Tamoxifen Citrate
Rosemont Pharmaceuticals LtdSoltamox
Teva Pharmaceuticals USA, Inc.Tamoxifen Citrate